focus -WSS

focus

author：focus 2025-08-11 11:44:23 - browse：6

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： FDA official pushes for dedicated emerging pathogens team

focus

WSS

White House launches permanent pandemic office

Trump demands the U.S. pay no more for drugs than other countries … again

Russian special forces kill a gunman who broke into a private house near Moscow

In new study, freeze

7 of the most gruesome medical devices in history

Alkermes shareholders re

focus

focus

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

Tori Bowie and the unacceptable rates of Black maternal death

The cancer drug shortage isn’t new — and neither are the solutions

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A double vaccine crisis is endangering millions of children

New air purifier tech could be key to improving indoor air quality

Duchenne breakthrough therapy leaves behind pioneering families

Hollywood unions extend contract negotiations for actors

Drug repurposing or repositioning? The language matters

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

7 of the most gruesome medical devices in history

Court strikes down limits on filming of police in Arizona

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Organ transplantation is at a crossroads. Major reform is needed

Tori Bowie and the unacceptable rates of Black maternal death

hotspot

focus

focus

knowledge